PDGFR-β mediated growth failure in pediatric CML cases on Imatinib

作者: Prakamya Gupta , Pinaki Dutta

DOI: 10.1016/J.PHOJ.2020.06.012

关键词: ImatinibMedicinePlatelet-derived growth factor receptorCancer research

摘要:

参考文章(26)
Maynika V. Rastogi, Linda Stork, Brian Druker, Carolyn Blasdel, Thuan Nguyen, Bruce A. Boston, Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia Pediatric Blood & Cancer. ,vol. 59, pp. 840- 845 ,(2012) , 10.1002/PBC.24121
Kate Vandyke, AL Dewar, S Fitter, D Menicanin, LB To, TP Hughes, ACW Zannettino, None, Imatinib mesylate causes growth plate closure in vivo Leukemia. ,vol. 23, pp. 2155- 2159 ,(2009) , 10.1038/LEU.2009.150
L. Kebapcilar, O. Bilgir, I. Alacacioglu, B. Payzin, F. Bilgir, P. Oner, I. Sari, M. Calan, O. Binicier, Does imatinib mesylate therapy cause growth hormone deficiency Medical Principles and Practice. ,vol. 18, pp. 360- 363 ,(2009) , 10.1159/000226288
Karthik R. Narayanan, Deepak Bansal, Rama Walia, Naresh Sachdeva, Anil Bhansali, Neelam Varma, R.K. Marwaha, Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis. Pediatric Blood & Cancer. ,vol. 60, pp. 1148- 1153 ,(2013) , 10.1002/PBC.24397
Tomiko Kimoto, Masami Inoue, Keisei Kawa, Growth deceleration in a girl treated with imatinib. International Journal of Hematology. ,vol. 89, pp. 251- 252 ,(2009) , 10.1007/S12185-008-0251-8
Frédéric Millot, Joelle Guilhot, André Baruchel, Arnaud Petit, Thierry Leblanc, Yves Bertrand, Françoise Mazingue, Patrick Lutz, Cecile Vérité, Christian Berthou, Claire Galambrun, Nicolas Sirvent, Karima Yacouben, Pascal Chastagner, Virginie Gandemer, Yves Reguerre, Gérard Couillault, Tackwa Khalifeh, Fanny Rialland, Growth deceleration in children treated with imatinib for chronic myeloid leukaemia. European Journal of Cancer. ,vol. 50, pp. 3206- 3211 ,(2014) , 10.1016/J.EJCA.2014.10.007
Stefania Mariani, Fiorina Giona, Sabrina Basciani, Marina Brama, Lucio Gnessi, Low bone density and decreased inhibin-B/FSH ratio in a boy treated with imatinib during puberty The Lancet. ,vol. 372, pp. 111- 112 ,(2008) , 10.1016/S0140-6736(08)61023-5
Ran Guan, Yue Zhang, Jing Jiang, Catherine A. Baumann, Roy A. Black, Gerhard Baumann, Stuart J. Frank, Phorbol Ester- and Growth Factor-Induced Growth Hormone (GH) Receptor Proteolysis and GH-Binding Protein Shedding: Relationship to GH Receptor Down-Regulation1 Endocrinology. ,vol. 142, pp. 1137- 1147 ,(2001) , 10.1210/ENDO.142.3.8030
Jenny Drew, Seiji Fukumoto, Christopher G. Schultz, Natalie A. Sims, David T. Yeung, Timothy P. Hughes, Andrew C. W. Zannettino, Kate Vandyke, Stephen Fitter, Prospective histomorphometric and DXA evaluation of bone remodeling in imatinib-treated CML patients: evidence for site-specific skeletal effects. The Journal of Clinical Endocrinology and Metabolism. ,vol. 98, pp. 67- 76 ,(2013) , 10.1210/JC.2012-2426
Maria Arantzazu Sanchez-Fernandez, Anne Gallois, Thilo Riedl, Pierre Jurdic, Bernard Hoflack, Osteoclasts Control Osteoblast Chemotaxis via PDGF-BB/PDGF Receptor Beta Signaling PLOS ONE. ,vol. 3, ,(2008) , 10.1371/JOURNAL.PONE.0003537